Cefotaxime: Clinical Trials

29 trials of Cefotaxime, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 7 unknown, 3 recruiting, 1 enrolling by invitation. 9 Phase 4, 8 Not applicable, 6 Phase 3, 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 49Completed 5, Unknown 3, Recruiting 1
Not applicable8Completed 4, Unknown 3, Enrolling by invitation 1
Phase 36Completed 4, Recruiting 1, Unknown 1
Phase 24Completed 3, Recruiting 1
Phase 12Completed 2
Early Phase 11Terminated 1

Follow Cefotaxime: new trials by email Literature Review of Cefotaxime trials Research Report on Cefotaxime

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Duration of Perioperative Antibiotics in Pancreatoduodenectomy
single dose preoperative antibiotic, Prolonged perioperative antibiotics - Pancreatoduodenectomy, PPPD
Not applicableEnrolling by invitationAsan Medical Center5582026-05-112026-05-28
Aminoglycosides in Early Sepsis
Gentamicin + narrow spectrum betalactam, Cefotaxime, Piperacillin-tazobactam - Sepsis
Phase 4RecruitingUniversity Hospital, Akershus19002026-04-232026-10-28
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-11-12
Meropenem vs Cefotaxime as Empirical Treatment of SBP
cefotaxime - Spontaneous Bacterial Peritonitis
Phase 4UnknownAssiut University2862023-01-012022-06-22
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
0.9% NaCl physiological saline Nasal-spraying, LiveSpo Navax®, Augmentin 500Mg Tablet - Upper Respiratory Tract Infections
Not applicableCompletedAnabio R&D1752021-10-282024-08-22
Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
Oral Paste(0,5 g) containing 10 mg of polymyxin B, 10 mg of gentamycin and 150 mg of amphotericine B or 500 000 U of nistatin q6h, Suspension (10 ml) containing 100 mg of polymyxin B, 80 mg of gentamycin, 350 mg of amphotericine B or 8000000 U of nistation and 500 mg of vancomycin q6h, Intravenous Antibacterial Agent - a 3-day course of systemic cefotaxime 1 g q6h or ceftriaxone 1 g qd - Pneumonia, Ventilator-Associated, Pneumonia
Not applicableUnknownMEDSI Clinical Hospital 1, ICU602021-05-012021-06-08
Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD
Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute
Phase 2 / Phase 3CompletedHaiphong University of Medicine and Pharmacy1702020-01-012021-05-10
Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria
Cefotaxime, Ceftriaxone - Infection, Bacterial
Not applicableCompletedFondation Hôpital Saint-Joseph342019-04-302021-08-16
Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
Cefotaxime, Gemifloxacin - Spontaneous Bacterial Peritonitis
Phase 3RecruitingTanta University602018-12-012019-11-19
Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)
Cefotaxime Injection, Rectal swab, Cefotaxime/ceftriaxone - Infectious Disease - Resistant Enterobacteriaceae (Diagnosis)
Phase 4UnknownCentre Hospitalier Universitaire de Besancon2502018-04-032019-04-22
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis
Phase 3CompletedThe George Institute200102017-05-012023-08-14
Antibiotic "Dysbiosis" in Preterm Infants
Antibiotic, Gastric fluid, Breast milk - Enterocolitis, Necrotizing, Bacteremia
Phase 2CompletedUniversity of Florida982017-01-162024-06-05
Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections
Temocillin, Cefotaxime - Urinary Tract Infections
Phase 4CompletedHåkan Hanberger1572016-05-202019-09-16
The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin, Appendectomy - Appendicitis
Not applicableCompletedUniversity of Washington15522016-05-012023-05-06
Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.
ceftriaxone, Cefotaxime - Emergence of Bacterial Resistance to Antibiotics
Phase 3CompletedAssistance Publique - Hôpitaux de Paris222016-03-012018-05-21
Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.
Cefotaxime - Critically Ill
Phase 4CompletedUniversity Medical Center Groningen602015-11-012016-10-27
Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis
Cefotaxime - Spontaneous Bacterial Peritonitis
Not applicableCompletedDr Ahmed Ali Elbaz2542015-03-012015-06-04
Laparoscopic Appendectomy for Uncomplicated Appendicitis: Does Antimicrobial Prophylaxis Really Matter?
cefamezin 1g IV, metronidazole 500 mg IV, Placebo - Appendicitis
Not applicableUnknownHaEmek Medical Center, Israel2882015-03-012015-03-31
Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?
Cefotaxime, ceftriaxone - Primary Bacterial Peritonitis
Phase 3UnknownTanta University1002015-01-012017-06-20
Patients Response to Early Switch To Oral:Osteomyelitis Study
oral antibiotics, intravenous antibiotics - Osteomyelitis
Early Phase 1TerminatedJulio Ramirez112014-03-062021-04-06

Showing 20 of 29. Sign in to see all of them.

Conditions studied

Sepsis (4)  ·  Appendicitis (3)  ·  Critical Illness (3)  ·  Pneumonia, Ventilator-Associated (3)  ·  Bacterial Infections (2)  ·  Respiratory Tract Infections (2)  ·  Anaphylaxis (1)  ·  Bacteremia (1)  ·  Brain Injuries (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Coinfection (1)  ·  Diabetes Mellitus (1)  ·  Disease (1)  ·  Drug Hypersensitivity (1)  ·  Enterocolitis, Necrotizing (1)

Sponsors

Centre Hospitalier Universitaire de Besancon (2)  ·  Tanta University (2)  ·  Anabio R&D (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Dr Ahmed Ali Elbaz (1)  ·  Fondation Hôpital Saint-Joseph (1)  ·  Göteborg University (1)  ·  HaEmek Medical Center, Israel (1)  ·  Haiphong University of Medicine and Pharmacy (1)  ·  Håkan Hanberger (1)  ·  Jinling Hospital, China (1)  ·  Julio Ramirez (1)  ·  Korea University (1)

Countries

France (5)  ·  United States (4)  ·  Egypt (3)  ·  Italy (2)  ·  South Korea (2)  ·  Sweden (2)  ·  Vietnam (2)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Alina Tone, MD (1)  ·  Anthony Gordon, MD FRCA (1)  ·  Binh Nguyen Thanh, Assoc. Prof. (1)  ·  Brian Cuthbertson, MD FRCA (1)  ·  Claudio Puoti, Prof (1)  ·  Dan Hershko, Professor (1)  ·  David A Khan, MD (1)  ·  David A Talan, MD (1)  ·  David R Flum, MD, MPH (1)  ·  David Seligson, MD (1)  ·  Dmitry Azovskiy, MD, phD (1)  ·  Eric M Senneville, MD, PhD (1)

Results publications

PMID 15276398, PMID 15840453, PMID 16291576, PMID 19358184, PMID 19588358, PMID 21129208, PMID 22147550, PMID 22530208, PMID 22952580, PMID 23352693, PMID 24207137, PMID 25414157, PMID 26445823, PMID 26529126, PMID 28846337, PMID 28876707, PMID 29146633, PMID 30881387, PMID 30936104, PMID 31697336, PMID 33479274, PMID 35612859, PMID 35796152, PMID 35815898, PMID 36197656, PMID 36286097, PMID 36594820, PMID 37308133, PMID 37379001, PMID 37982826, PMID 38045525, PMID 39373498, PMID 39870748, PMID 41159880, PMID 42642777, PMID 4902833, PMID 8948280

NIH funding

2014 (1), 2015 (1), R21HD088005 (1), U01AI184071 (1)